GWS
AKYA

Glassman Wealth Services’s Akoya BioSciences AKYA Stock Holding History

Glassman Wealth Services’s Portfolio AKYA Stock Details AKYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-50
Closed -$244 – 262
2023
Q4 		$244 Buy
50
+11
+28% +$46 ﹤0.01% 1855
2023
Q3 		$181 Buy
+39
New +$224 ﹤0.01% 1905
2023
Q1 		– Sell
-14
Closed -$134 – 1895
2022
Q4 		$134 Sell
14
-52
-79% -$640 ﹤0.01% 1856
2022
Q3 		$1K Buy
+66
New +$869 ﹤0.01% 1316

Other funds holding AKYA

BWLSA
Blue Water Life Science Advisors Larkspur, California $125M AUM 91.82% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
SW
SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Glassman Wealth Services's AKYA Position: Q1 2024 in Review

Glassman Wealth Services sold out of Akoya BioSciences (AKYA) in Q1 2024, closing a stake of 50 shares — an estimated $244 sold.

Glassman Wealth Services first reported a position in AKYA in Q3 2022 and held it in 4 quarters. The position peaked at $1K in Q3 2022. 68 funds tracked by Wall St. Rank hold AKYA as of Q1 2024.

  • Glassman Wealth Services reported no remaining Akoya BioSciences position as of Q1 2024 after selling out during the quarter.
  • Glassman Wealth Services sold 50 Akoya BioSciences shares in Q1 2024, an estimated $244.
  • Glassman Wealth Services first reported a position in Akoya BioSciences in Q3 2022 and held it in 4 quarters.
  • Glassman Wealth Services's Akoya BioSciences position peaked at $1K in Q3 2022.
  • 68 funds tracked by Wall St. Rank held Akoya BioSciences as of Q1 2024.

Based on Glassman Wealth Services's 13F filing for Q1 2024, filed 3 May 2024.